Cargando…

Utilizing V—Y fasciocutaneous advancement flaps for vulvar reconstruction

OBJECTIVES: We aimed to analyze the outcomes of patients who underwent vulvectomy with subsequent V—Y fasciocutaneous flap reconstruction. METHODS: All medical records of all patients who underwent vulvectomies with V—Y fasciocutaneous flap reconstruction from January 2007 to June 2016 were retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hand, Lauren C., Maas, Talia M., Baka, Nadia, Mercier, Rebecca J., Greaney, Patrick J., Rosenblum, Norman G., Kim, Christine H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122364/
https://www.ncbi.nlm.nih.gov/pubmed/30186930
http://dx.doi.org/10.1016/j.gore.2018.08.007
_version_ 1783352641054572544
author Hand, Lauren C.
Maas, Talia M.
Baka, Nadia
Mercier, Rebecca J.
Greaney, Patrick J.
Rosenblum, Norman G.
Kim, Christine H.
author_facet Hand, Lauren C.
Maas, Talia M.
Baka, Nadia
Mercier, Rebecca J.
Greaney, Patrick J.
Rosenblum, Norman G.
Kim, Christine H.
author_sort Hand, Lauren C.
collection PubMed
description OBJECTIVES: We aimed to analyze the outcomes of patients who underwent vulvectomy with subsequent V—Y fasciocutaneous flap reconstruction. METHODS: All medical records of all patients who underwent vulvectomies with V—Y fasciocutaneous flap reconstruction from January 2007 to June 2016 were retrospectively reviewed. Patient clinical and surgical data, demographics, and outcomes were abstracted. RESULTS: Of the 27 patients, 42 flaps were transferred. A simple vulvectomy was performed in 8 (30%) patients, partial radical vulvectomy in 15 (56%), and radical vulvectomy in 4 (15%). The median area of defect was 30 cm(2). Minor wound separations occurred in 9 patients (33%). Infectious complications occurred in 4 patients (15%); this included urinary tract infections in 2 (50%), postoperative fevers in 2 (50%), and sepsis in 1 (25%) patient with a UTI. There were no instances of flap necrosis, wound dehiscence, or wound infections. Black race was more likely to be associated with an infectious complication with 3 (75%) patients, compared to white race with 1 (4%) patient (p < .01). The presence of diabetes was more likely to be associated with an infectious complication in 2 (67%) patients, compared to 1 (4%) in non-diabetic patients (p < .01). No other significant association was found during analysis of demographics, medical comorbidities, vulvar pathology, or surgical factors affecting V—Y fasciocutaneous flap infectious complications or minor wound separations. CONCLUSIONS: The use of a V—Y fasciocutaneous advancement flap for vulvar reconstruction is safe and associated with mostly minor complications. Infectious complications were more frequently associated with diabetes, black race, and HIV.
format Online
Article
Text
id pubmed-6122364
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-61223642018-09-05 Utilizing V—Y fasciocutaneous advancement flaps for vulvar reconstruction Hand, Lauren C. Maas, Talia M. Baka, Nadia Mercier, Rebecca J. Greaney, Patrick J. Rosenblum, Norman G. Kim, Christine H. Gynecol Oncol Rep Case Series OBJECTIVES: We aimed to analyze the outcomes of patients who underwent vulvectomy with subsequent V—Y fasciocutaneous flap reconstruction. METHODS: All medical records of all patients who underwent vulvectomies with V—Y fasciocutaneous flap reconstruction from January 2007 to June 2016 were retrospectively reviewed. Patient clinical and surgical data, demographics, and outcomes were abstracted. RESULTS: Of the 27 patients, 42 flaps were transferred. A simple vulvectomy was performed in 8 (30%) patients, partial radical vulvectomy in 15 (56%), and radical vulvectomy in 4 (15%). The median area of defect was 30 cm(2). Minor wound separations occurred in 9 patients (33%). Infectious complications occurred in 4 patients (15%); this included urinary tract infections in 2 (50%), postoperative fevers in 2 (50%), and sepsis in 1 (25%) patient with a UTI. There were no instances of flap necrosis, wound dehiscence, or wound infections. Black race was more likely to be associated with an infectious complication with 3 (75%) patients, compared to white race with 1 (4%) patient (p < .01). The presence of diabetes was more likely to be associated with an infectious complication in 2 (67%) patients, compared to 1 (4%) in non-diabetic patients (p < .01). No other significant association was found during analysis of demographics, medical comorbidities, vulvar pathology, or surgical factors affecting V—Y fasciocutaneous flap infectious complications or minor wound separations. CONCLUSIONS: The use of a V—Y fasciocutaneous advancement flap for vulvar reconstruction is safe and associated with mostly minor complications. Infectious complications were more frequently associated with diabetes, black race, and HIV. Elsevier 2018-08-24 /pmc/articles/PMC6122364/ /pubmed/30186930 http://dx.doi.org/10.1016/j.gore.2018.08.007 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Series
Hand, Lauren C.
Maas, Talia M.
Baka, Nadia
Mercier, Rebecca J.
Greaney, Patrick J.
Rosenblum, Norman G.
Kim, Christine H.
Utilizing V—Y fasciocutaneous advancement flaps for vulvar reconstruction
title Utilizing V—Y fasciocutaneous advancement flaps for vulvar reconstruction
title_full Utilizing V—Y fasciocutaneous advancement flaps for vulvar reconstruction
title_fullStr Utilizing V—Y fasciocutaneous advancement flaps for vulvar reconstruction
title_full_unstemmed Utilizing V—Y fasciocutaneous advancement flaps for vulvar reconstruction
title_short Utilizing V—Y fasciocutaneous advancement flaps for vulvar reconstruction
title_sort utilizing v—y fasciocutaneous advancement flaps for vulvar reconstruction
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122364/
https://www.ncbi.nlm.nih.gov/pubmed/30186930
http://dx.doi.org/10.1016/j.gore.2018.08.007
work_keys_str_mv AT handlaurenc utilizingvyfasciocutaneousadvancementflapsforvulvarreconstruction
AT maastaliam utilizingvyfasciocutaneousadvancementflapsforvulvarreconstruction
AT bakanadia utilizingvyfasciocutaneousadvancementflapsforvulvarreconstruction
AT mercierrebeccaj utilizingvyfasciocutaneousadvancementflapsforvulvarreconstruction
AT greaneypatrickj utilizingvyfasciocutaneousadvancementflapsforvulvarreconstruction
AT rosenblumnormang utilizingvyfasciocutaneousadvancementflapsforvulvarreconstruction
AT kimchristineh utilizingvyfasciocutaneousadvancementflapsforvulvarreconstruction